“Pay to Delay” Pharmaceutical Settlements: A Consumer Perspective

There has been increasing litigation, particularly within the last decade amongst consumers, the FTC, branded drug manufacturers, and generic drug manufacturers, since the 1984 enactment of Drug Price Competition and Patent Term Restoration Act, commonly known as the Hatch-Waxman Act. This controversy presents a unique dilemma to consumers, who would like to think that the … Continued


Expert Witnesses as Investigators of the Greater Story

From 2008-2010, there was a rash of headlines around pharmaceutical manufacturers manipulating study data and publication of study data.  The issue came to light through the work of several expert witnesses.  What you may not have realized is that those claims were proven with largely public data. Litigation attorneys so often focus upon the discovery … Continued